BioSpace News Archive

Drug Development

Flex Pharma Reports Second Quarter 2018 Financial Results

Flex Pharma, Inc. today announced its financial results for the three months ended June 30, 2018.

August 1, 2018
·
5 min read
Business

Platelet BioGenesis Moves to New Cambridge Lab Space to Support Continued Growth

Move to Nest.Bio Labs comes as company advances its program to commercialize a donor-independent source of lifesaving platelets

August 1, 2018
·
3 min read
Biotech Beach

Imprimis Announces Multi-Center Clinical Trial for Dropless® TriMoxi™ (Triamcinolone Acetonide-Moxifloxacin for injection) Formulation in Canada

Study to assess drug safety, patient preference and pharmacoeconomic measures in 200 routine cataract surgeries

August 1, 2018
·
6 min read
Business

Rigel Announces Conference Call and Webcast to Report Second Quarter 2018 Financial Results

Rigel Pharmaceuticals, Inc. announced that it will report its second quarter 2018 financial results after market close on Wednesday, August 8, 2018.

August 1, 2018
·
1 min read
Drug Development

Arrowhead Pharmaceuticals Earns $10 Million Milestone Payment from Amgen

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $10 million milestone payment from Amgen.

August 1, 2018
·
3 min read
BioMidwest

Exact Sciences Selects Vodori’s Pepper Flow to Support Commercialization of Cologuard

Pepper Flow supports Exact Sciences growth of sales and marketing materials while maintaining strict regulatory compliance

August 1, 2018
·
3 min read
Deals

Akumin Inc. Agrees to Acquire US$27.5 Million Revenue Business in Florida

This acquisition is expected to add approximately US$27.5 million of revenue based on the last twelve months of the period ended March 31, 2018

August 1, 2018
·
2 min read
Genetown

Torque Announces Proprietary Slipstream™ Platform for High-Efficiency Manufacturing of Deep-Primed T-Cell Therapies

UC Davis Good Manufacturing Practice facility to supply initial clinical trials using Slipstream manufacturing platform

August 1, 2018
·
5 min read
Job Trends

Heska to Present at Canaccord Genuity 38th Annual Growth Conference on August 8th

Heska Corporation announced that Kevin Wilson, Heska’s President & Chief Executive Officer will be presenting in a Fireside Chat at the Canaccord Genuity 38th Annual Growth Conference at 2:30 p.m. ET on Wednesday, August 8, 2018.

August 1, 2018
·
1 min read
FDA

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s FLT3 Inhibitor Quizartinib for Relapsed/Refractory FLT3-ITD AML

Quizartinib has received FDA Breakthrough Therapy designation in patients with relapsed/refractory FLT3-ITD AML, a very aggressive form of the disease associated with poor prognosis

August 1, 2018
·
6 min read